newsfilter
← Latest News
Business Wire·

Catalent and Novo Holdings Receive European Commission Unconditional Approval for Pending Transaction

Transaction Expected to Close Towards the End of Calendar Year 2024 Catalent, Inc. (("Catalent, NYSE:CTLT), a leader in enabling the development and supply of better treatments for patients worldwide, and Novo